XML 25 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
ASSETS:    
Cash and due from banks $ 1,155 $ 1,037
Interest-bearing cash and due from banks 8,003 11,696
Interest-bearing deposits in banks 316 306
Debt securities available for sale, at fair value (including $640 and $549 pledged to creditors, respectively) [1] 26,067 22,942
Debt securities held to maturity (fair value of $2,289 and $3,357, respectively, and including $77 and $144 pledged to creditors, respectively) [1] 2,242 3,235
Loans held for sale, at fair value 2,733 3,564
Other loans held for sale 735 439
Loans and leases 128,163 123,090
Less: Allowance for loan and lease losses (1,758) (2,443)
Net loans and leases 126,405 120,647
Derivative assets 1,216 1,915
Premises and equipment, net 768 759
Bank-owned life insurance 2,843 1,756
Goodwill 7,116 7,050
Other assets 8,810 8,003
TOTAL ASSETS 188,409 183,349
Deposits:    
Noninterest-bearing 49,443 43,831
Interest-bearing 104,918 103,333
Total deposits 154,361 147,164
Short-term borrowed funds 74 243
Derivative liabilities 197 128
Deferred taxes, net 0 629
Long-term borrowed funds 6,932 8,346
Other liabilities 3,425 4,166
TOTAL LIABILITIES 164,989 160,676
Contingencies (refer to Note 19)
STOCKHOLDERS’ EQUITY:    
$25.00 par value,100,000,000 shares authorized; 2,050,000 and 2,000,000 shares issued and outstanding at December 31, 2021 and 2020, respectively 2,014 1,965
Common stock:    
$0.01 par value, 1,000,000,000 shares authorized; 571,259,135 shares issued and 422,137,197 shares outstanding at December 31, 2021 and 569,876,133 shares issued and 427,209,831 shares outstanding at December 31, 2020 6 6
Additional paid-in capital 19,005 18,940
Retained earnings 7,978 6,445
Treasury stock, at cost, 149,121,938 and 142,666,302 shares at December 31, 2021 and 2020, respectively (4,918) (4,623)
Accumulated other comprehensive income (loss) (665) (60)
TOTAL STOCKHOLDERS’ EQUITY 23,420 22,673
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 188,409 $ 183,349
[1] Includes only collateral pledged by the Company where counterparties have the right to sell or pledge the collateral.